u 69593 has been researched along with bw 373u86 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burgess, JP; Carroll, FI; Dersch, CM; Herault, XM; Horel, RB; Mascarella, SW; Rothman, RB; Thomas, JB; Xu, H | 1 |
| Atkinson, RN; Carroll, FI; Dersch, CM; Herault, XM; Horel, RB; Mascarella, SW; Rothman, RB; Thomas, JB; Xu, H | 1 |
| Atkinson, RN; Burgess, JP; Carroll, FI; Dersch, CM; Flippen-Anderson, JL; George, CF; Herault, XM; Mascarella, SW; Rothman, RB; Thomas, JB; Xu, H | 1 |
3 other study(ies) available for u 69593 and bw 373u86
| Article | Year |
|---|---|
(+/-)-4-[(N-allyl-cis-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide displays selective binding for the delta opioid receptor.
Topics: Benzamides; Piperazines; Piperidines; Radioligand Assay; Receptors, Opioid, delta | 1999 |
Optically pure (-)-4-[(N-allyl-3-methyl-4-piperidinyl)phenyl-amino]-N,N-diethylbenzami de displays selective binding and full agonist activity for the delta opioid receptor.
Topics: Benzamides; Brain; Piperidines; Radioligand Assay; Receptors, Opioid, delta | 1999 |
Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamides.
Topics: Animals; Benzamides; Brain; Crystallography, X-Ray; Guinea Pigs; In Vitro Techniques; Ligands; Piperazines; Piperidines; Radioligand Assay; Rats; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Stereoisomerism; Structure-Activity Relationship | 2001 |